Welcome to our newly created Center for Innovative Training in Vocational Rehabilitation (CIT-VR). The Center’s focus is on developing innovative methods to train VR personnel in their work at State Vocational Rehabilitation agencies to deliver services to improve employment outcomes for individuals with disabilities. More about the Center…
Join us for webinars on topics relevant to Vocational Rehabilitation professionals.
CIT-VR Communities of Practice (CoPs)
Want to be a part of identifying topics and exploring training needs?
Access to courses and training for VR professionals.
About the Center
The George Washington University Center for Rehabilitation Counseling Research and Education, in partnership with San Diego State University and the Council of State Administrators of Vocational Rehabilitation, welcomes you to our newly created Center for Innovative Training in Vocational Rehabilitation (CIT-VR).*
The Center’s focus is on developing innovative methods to train VR personnel to support the work of State Vocational Rehabilitation agencies in delivering rehabilitation services and to improve employment outcomes for individuals with disabilities.
In year one of the project, CIT-VR will select 10 states to receive access to online training modules for their personnel that focuses on core components of the rehabilitation process including:
- Eligibility Determination
- Conducting a comprehensive assessment
- Developing an Individualized Plan for Employment (IPE)
- Job development and placement
- Case closure
The Center will also offer a number of webinars on a variety of topical areas based on the results of an assessment of training needs of State VR agencies, as well offering virtual Communities of Practice.
Dr. Maureen McGuire-Kuletz, Principle Investigator: firstname.lastname@example.org
John C. Walsh, Project Director: email@example.com
*This project is funded through a grant from the US Department of Education, Rehabilitation Services Administration under the Innovative Rehabilitation Training Program (CFDA 84.263C).